Finance

Lists
4967:TYO
Kobayashi Pharmaceutical Co Ltd
Â¥5,617.00
+2.63%
(+144.00) 1D
Aug 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4967...
Open
Â¥5,498
High
Â¥5,651
Low
Â¥5,450
Mkt. cap
438.41B
Avg. vol.
255.12K
Volume
287.90K
Dividend
1.87%
Quarterly dividend
Â¥26
Ex-dividend date
Jun 29, 2026
P/E ratio
136.10
52-wk high
Â¥6,140
52-wk low
Â¥5,030
EPS
Â¥41
Shares outstanding
79.07M
No. of employees
4K
Open
Â¥5,498
High
Â¥5,651
Low
Â¥5,450
Mkt. cap
438.41B
Avg. vol.
255.12K
Volume
287.90K
Dividend
1.87%
Quarterly dividend
Â¥26
Ex-dividend date
Jun 29, 2026
P/E ratio
136.10
52-wk high
Â¥6,140
52-wk low
Â¥5,030
EPS
Â¥41
Shares outstanding
79.07M
No. of employees
4K
About Kobayashi Pharmaceutical Co Ltd
CEOKazumasa Kobayashi
Employees3.73K
FoundedAug 22, 1919
Headquarters-
SectorPersonal care products
Websitekobayashi.co.jp
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
35.38B / 37.51B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
43.02B
53.70B
35.38B
35.38B
Cost of goods sold
20.30B
27.85B
17.21B
17.21B
Cost of revenue
20.30B
27.85B
17.21B
17.21B
Research and development expenses
-
9.12B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.87B
6.76B
17.10B
17.10B
Operating expense
17.87B
22.50B
17.10B
17.10B
Total operating expenses
38.17B
50.36B
34.31B
34.31B
Operating income
4.85B
3.35B
1.06B
1.06B
Other non operating income
593.00M
-150.00M
-530.00M
-530.00M
EBT including unusual items
5.02B
-5.52B
1.11B
1.11B
EBT excluding unusual items
5.68B
4.07B
829.50M
829.50M
Income tax expense
1.37B
-2.37B
541.00M
541.00M
Effective tax rate
27.33%
42.97%
48.76%
48.76%
Other operating expenses
-
1.26B
-
-
Net income
3.64B
-3.15B
568.00M
568.00M
Net profit margin
8.47%
-5.87%
1.61%
1.61%
Earnings per share
-
-
-
-
Interest and investment income
94.00M
448.00M
295.50M
295.50M
Interest expense
-3.00M
-13.00M
-5.00M
-5.00M
Net interest expenses
91.00M
435.00M
290.50M
290.50M
Depreciation and amortization charges
-
3.89B
-
-
EBITDA
6.85B
5.53B
3.45B
3.45B
Gain or loss from assets sale
-
-
39.50M
39.50M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps